REBECCA AIKEY: Open Payments
NPI 1265866834 · BEDFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 23 payments from 12 companies in 2025. Trend: 2023 $129 · 2024 $58 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 5 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Lilly USA, LLC | 3 | $42 |
| Novo Nordisk Inc | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Abbott Laboratories | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: SUBLOCADE, CAPLYTA, Kerendia, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, KEVEYIS, XIFAXAN, PREVNAR 20.
Industry payments across PA — which companies pay providers there.
